C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/29/2004	CA2530191A1 Method for the detection of gene transcripts in blood and uses thereof
12/29/2004	CA2529793A1 Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
12/29/2004	CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions
12/29/2004	CA2529651A1 Test strip with flared sample receiving chamber
12/29/2004	CA2529639A1 Detection of survivin in the biological fluids of cancer patients
12/29/2004	CA2529633A1 Methods for the diagnosis and prognosis of alzheimer's disease
12/29/2004	CA2529589A1 New biological entities and the pharmaceutical or diagnostic use thereof
12/29/2004	CA2529378A1 Method and reagent for producing narrow, homogenous reagent strips
12/29/2004	CA2529246A1 Method of producing recombinant dna molecules
12/29/2004	CA2529142A1 Rna interferases and methods of use thereof
12/29/2004	CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	CA2528529A1 Gene amplification and overexpression in cancer
12/29/2004	CA2526648A1 Method for producing a synthetic gene or other dna sequence
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/29/2004	CA2526423A1 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
12/29/2004	CA2525847A1 Tissue modeling in embryonic stem (es) cell system
12/29/2004	CA2524567A1 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/28/2004	US6835946 Image reading method and apparatus
12/28/2004	US6835826 Acid resistance, stability; telomerase inhibitor
12/28/2004	US6835822 Diagnosis and therapy of cancer using SGP28-related molecules
12/28/2004	US6835816 Mammalian tumor susceptibility genes and their uses
12/28/2004	US6835569 Amino polyol oxidase amine polynucleotides and related polypeptides and methods of use
12/28/2004	US6835567 PNS cell lines and methods of use therefor
12/28/2004	US6835565 Alzheimer's disease secretase
12/28/2004	US6835561 Composition of reverse transcriptases and mutants thereof
12/28/2004	US6835553 Photometric glucose measurement system using glucose-sensitive hydrogel
12/28/2004	US6835548 Isoforms of mouse serotonin 5-HT2c receptor
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835542 For providing kinetic and thermodynamic components in an assay for detecting target sequences
12/28/2004	US6835541 Aberrantly methylated genes as markers of breast malignancy
12/28/2004	US6835538 Method of genetic modification of a wild type viral sequence
12/28/2004	US6835537 Method for equalizing band intensities on sequencing gels
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/26/2004	CA2470966A1 Pharmacophore model generation and use
12/23/2004	WO2004111914A2 Efficient methods for multibody simulations
12/23/2004	WO2004111832A1 Improved method for diagnosing and treating breast cancer
12/23/2004	WO2004111647A1 Analysis of a microarray data set
12/23/2004	WO2004111644A1 Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
12/23/2004	WO2004111626A1 A mass amplified piezoelectric biochip
12/23/2004	WO2004111620A1 Bioassay substrate and bioassay device and method
12/23/2004	WO2004111612A2 Porous nanostructures and methods involving the same
12/23/2004	WO2004111610A2 Method and system for the analysis of high density cells samples
12/23/2004	WO2004111606A2 Automated microbiological testing apparatus and method
12/23/2004	WO2004111603A2 Gene expression markers for predicting response to chemotherapy
12/23/2004	WO2004111602A2 Colorimetric and fluorescent methods for sensing of oligonucleotides
12/23/2004	WO2004111274A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of sars coronavirus
12/23/2004	WO2004111273A2 Gene expression markers for response to egfr inhibitor drugs
12/23/2004	WO2004111272A2 Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer
12/23/2004	WO2004111271A2 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs
12/23/2004	WO2004111270A2 Differential gene expression in schizophrenia
12/23/2004	WO2004111269A1 Method for the real-time quantification of a nucleic acid
12/23/2004	WO2004111268A2 Mutations in the slc40a1 gene associated to impaired iron homeostasis
12/23/2004	WO2004111266A1 Methods for genome amplification
12/23/2004	WO2004111265A1 A kit for the detection of urease
12/23/2004	WO2004111264A1 Bacterial biofilm assay employing magnetic beads
12/23/2004	WO2004111263A1 Culture medium for detecting salmonella
12/23/2004	WO2004111262A1 Method of identifying a selective chemotherapeutic agent
12/23/2004	WO2004111261A1 Carbon-phosphorus or carbon-arsenic bond-containing moieties suitable for linking to antimicrobial agent
12/23/2004	WO2004111259A2 Hydrolytic substrates for an analyte-dependent enzyme activation system
12/23/2004	WO2004111257A1 Method for the microbiological isomerisation of alpha-hydroxy carboxylic acids
12/23/2004	WO2004111232A1 Method of detecting target antigen
12/23/2004	WO2004111231A1 Genetic polymorphism detection kit
12/23/2004	WO2004111229A1 Methylomic analysis-cytosine cellular signatures
12/23/2004	WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
12/23/2004	WO2004111200A2 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer
12/23/2004	WO2004111197A2 Gene expression signatures, methods and compositions for diagnosing disorders of the lung
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111190A2 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES
12/23/2004	WO2004111187A2 Methods for identification of coronaviruses
12/23/2004	WO2004111186A2 Monitoring for and detecting microbes used in bioterrorism
12/23/2004	WO2004111180A2 Methods and compositions for selectively enriching microbes
12/23/2004	WO2004111075A2 Alternative reading frame polypeptides for treatment
12/23/2004	WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
12/23/2004	WO2004110476A1 Pharmaceutcal composition for treating or preventing disorders of blood-brain barrier
12/23/2004	WO2004110384A2 Hiv-1 envelope glycoproteins having unusual disulfide structure
12/23/2004	WO2004110365A2 Liver related disease compositions and methods
12/23/2004	WO2004110246A2 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns
12/23/2004	WO2004110244A2 A gene equation to diagnose rheumatoid arthritis
12/23/2004	WO2004110243A2 COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPsc
12/23/2004	WO2004099755A3 Method of electrochemical detection of somatic cell mutations
12/23/2004	WO2004097051A3 Methods for diagnosing aml and mds differential gene expression
12/23/2004	WO2004097039A9 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
12/23/2004	WO2004094673A8 Methods for monitoring drug activities in vivo
12/23/2004	WO2004094663A3 Method for identifying characteristics of molecules by converting said characteristics into a polynucleotide sequence
12/23/2004	WO2004089182A3 Anti-retroviral analysis by mass spectrometry
12/23/2004	WO2004087894A9 Bacterial aggregates
12/23/2004	WO2004086941A3 System and method for rapidly identifying pathogens, bacteria and abnormal cells
12/23/2004	WO2004083386A3 Methods of making repetitive sequences removed probes and use thereof
12/23/2004	WO2004083366A3 Methods utilizing novel target genes related to immune-mediated diseases
12/23/2004	WO2004082571A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86)
12/23/2004	WO2004081221A3 Pre-incubation method to improve signal/noise ratio of nucleic acid assays
12/23/2004	WO2004080270A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
12/23/2004	WO2004076684A3 Compositions and methods for the detection of mammalian muscle troponin i
12/23/2004	WO2004074310A8 Mycobacterial diagnostics
12/23/2004	WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using
12/23/2004	WO2004072263A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/23/2004	WO2004072229A3 Chemical treatment of biological samples for nucleic acid extraction and kits therefor
12/23/2004	WO2004071179A3 Method of assaying for high performance mammals
12/23/2004	WO2004067779A3 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof

1 ... 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 ... 3003